Yi-fan Zhou
Key Laboratory Of Breast Cancer In Shanghai
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
NK Cell Activation by Platinum Boosts Immunotherapy in HR+/HER2- Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 26, 2025
TNBC's compass: Navigating prognosis with a cellular map.
Journal: Cancer cell
Published: June 23, 2025
Comprehensive genomic profiling of triple-negative breast cancer metastases identifies role of PKD1 in immunotherapy resistance.
Journal: The Journal of clinical investigation
Published: November 18, 2024
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.
Journal: Nature cancer
Published: December 02, 2022
Molecular classification of hormone receptor-positive HER2-negative breast cancer.
Journal: Nature genetics
Published: June 19, 2022
Integrated analysis reveals prognostic value of HLA-I LOH in triple-negative breast cancer.
Journal: Journal for immunotherapy of cancer
Published: August 29, 2021
Application of modified mini-clinical evaluation exercise in the cultivation of orthopaedic students.
Journal: International journal of clinical practice
Published: October 09, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026